VRCI
Verde Science, Inc.

Mr. Sangha has been a founder, CEO and board member of several public companies and brings over 30 years of entrepreneurial, operational and capital market experience to Barrel. I He has also served in the several executive positions for a number of public companies such as Sharprock Resources Inc., Rango Energy, Inc., Verde Science and Black Cactus Global . Mr. Sangha has established many valuable contacts and has extensive institutional relationships worldwide.

Mr. Alexander is a chartered accountant who graduated from the University of British Columbia with a BComm in Finance. He has managed the rapid growth of several early stage startup companies to major successes in their respective sectors. As CFO of the start-up Nortran Pharmaceuticals, Inc., a University of British Colombia based pharmaceutical research and development company engaged in the development and commercialization of cardiovascular therapies, he assisted in obtaining its initial financing and first discoveries. While at Nortran he worked closely with Dr. Walker and a group of scientists who had a vision to create solutions for life threatening arrhythmias of the heart, acute cough, and pain management. Nortran subsequently became Cardiome Pharma Corp., a successful Vancouver BC based pharmaceutical company listed on Nasdaq: CRME. While CFO of Arakis Energy Corporation, he managed its growth from startup to over a billion dollars in assets, and moved its public company listing from the Vancouver Stock Exchange to Nasdaq in New York. Arakis was an international oil and gas development company with wells in Kentucky, Oman, New Guinea and the Sudan. The company was subsequently sold to Talisman Energy Inc. and oil fields developed by Arakis have resulted in proven developed and undeveloped reserves of over 500 million barrels. The fields have been producing over 350,000 barrels per day for the last 15 years. During his tenure as CFO and controller at Columbia Trust Company, he managed the growth of its assets from $50 million to over $1 billion during a 5-year period. He implemented a comprehensive management system that enabled him to reduce administrative staff from 50 to 15, and managed a $20 million money market and stock portfolio. David left Columbia Trust when it was sold to a Toronto based trust company.

Mr. Alford holds both an Honors Bachelor of Science and a Master's Degree in Science and is a registered Professional Geoscientist. Mr. Alford has wide-ranging project and business development experience, having worked throughout North and South America, Central Asia, Australia, Africa, Russia and China. His experience has included work on the exploration, operations and the analysis of both conventional energy and new energy projects for several junior and major multinational companies. Mr. Alford has played key roles in raising equity for new projects and developing comprehensive economic analysis for billion-dollar M&A transactions.

Mr. Patel earned a Bachelor in Pharmaceutical Sciences from The Institute of Chemical Technology in Mumbai, India, and an MBA from Queensland University of Technology in Brisbane, Australia. He was Director of Business Development for Sterkem Group, a Mumbai, India based pharmaceutical R&D, production, and marketing firm. At Sterkem he was responsible for business strategy and new product development, reporting directly to the Board of Directors. He successfully restructured the marketing and manufacturing operations to improve profitability. He was responsible for training a sales team of 150 sales representatives including 15 province managers. Subsequently, he was a market research manager at iData Research, an international market research consulting company dedicated to the provision of business intelligence for the medical device, dental and pharmaceutical industries. He managed global accounts for business development and consulting for cardiovascular devices and therapies. He built relationships with existing and new clients, and enhanced the growth potential of the company by working with the Analyst Team for new product development. Mr. Patel has a broad network of international business contacts throughout the pharmaceutical sector, which will be an important resource for Verde Science as it moves forward with its growth plans. He is a creative problem solver with focus on strategic planning to ensure continuous long-term success. He excels at business development by building relationships and engaging C-Level decision makers and his excellent interpersonal skills help him relate to culturally diverse audiences and managing staff in different countries across numerous time zones.

Mr. Sangha began his career as an investment advisor at Global Securities Corporation in 2004 and focused on the natural resource and mining sector where he worked till 2010. Over that period Mr. Sangha built a network of retail and institutional investors across North America and Europe. Mr. Sangha left Global Securities in 2010 and joined Douglas Lake Minerals as head of Investor Relations/Corporate Development. While working at Douglas Lake Minerals, Mr. Sangha focused on financing, investor presentations, and corporate relations. Mr. Sangha currently holds this position with Verde Science.

Mr. Sangha has been a founder, CEO and board member of several public companies and brings over 30 years of entrepreneurial, operational and capital market experience to Barrel. I He has also served in the several executive positions for a number of public companies such as Sharprock Resources Inc., Rango Energy, Inc., Verde Science and Black Cactus Global . Mr. Sangha has established many valuable contacts and has extensive institutional relationships worldwide.

Mr. Alford holds both an Honors Bachelor of Science and a Master's Degree in Science and is a registered Professional Geoscientist. Mr. Alford has wide-ranging project and business development experience, having worked throughout North and South America, Central Asia, Australia, Africa, Russia and China. His experience has included work on the exploration, operations and the analysis of both conventional energy and new energy projects for several junior and major multinational companies. Mr. Alford has played key roles in raising equity for new projects and developing comprehensive economic analysis for billion-dollar M&A transactions.